Get the Stockscreener App
1.87
6.03%
-0.12
Equillium Inc stock is traded at $1.87, with a volume of 686.27K.
It is down -6.03% in the last 24 hours and up +100.19% over the past month.
Equillium Inc is a clinical-stage biotechnology company engaged in developing novel therapeutics to treat severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. The company intends to commercialize its product candidates either independently or through partnerships, or otherwise monetize its pipeline through strategic transactions. Itolizumab (EQ001), a clinical-stage product candidate, is an anti-CD6 immune-modifying monoclonal antibody, or mAb, that selectively targets the CD6-ALCAM signaling pathway to downregulate pathogenic T effector cells while preserving T regulatory cells critical for maintaining a balanced immune response. The company's other clinical-stage and pre-clinical-stage candidates include EQ101 and EQ302.
See More
Previous Close:
$1.99
Open:
$1.96
24h Volume:
686.27K
Relative Volume:
0.09
Market Cap:
$111.27M
Revenue:
$45.91M
Net Income/Loss:
$-4.62M
P/E Ratio:
-13.34
EPS:
-0.1402
Net Cash Flow:
$-21.51M
1W Performance:
-2.09%
1M Performance:
+100.19%
6M Performance:
+149.33%
1Y Performance:
+114.94%
1-Day Range:
$1.86
$2.02
1-Week Range:
$1.78
$2.28
52-Week Range:
$0.27
$2.35
Equillium Inc Stock (EQ) Company Profile
Name
Equillium Inc
Sector
Industry
Phone
(858) 412-5302
Address
2223 AVENIDA DE LA PLAYA, LA JOLLA, CA
Compare EQ with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
EQ
Equillium Inc
|
1.87 | 109.49M | 45.91M | -4.62M | -21.51M | -0.1402 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Equillium Inc Stock (EQ) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-28-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Oct-29-21 | Resumed | Stifel | Buy |
| Sep-15-21 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-14-20 | Reiterated | H.C. Wainwright | Buy |
| Jul-10-20 | Resumed | Stifel | Buy |
| Feb-22-19 | Initiated | SVB Leerink | Outperform |
View All
Equillium Inc Stock (EQ) Latest News
Best data tools to analyze Equillium Inc. stockWeekly Earnings Recap & Stepwise Swing Trade Plans - newser.com
Backtesting results for Equillium Inc. trading strategiesJuly 2025 Short Interest & Weekly Breakout Watchlists - newser.com
Will a bounce in Equillium Inc. offer an exitWeekly Trend Recap & Smart Money Movement Tracker - newser.com
Using data filters to optimize entry into Equillium Inc.July 2025 Reactions & High Conviction Investment Ideas - newser.com
Key metrics from Equillium Inc.’s quarterly dataJuly 2025 Closing Moves & Safe Entry Zone Tips - Newser
Earnings visualization tools for Equillium Inc.July 2025 Momentum & Low Drawdown Momentum Trade Ideas - Newser
Will Equillium Inc. bounce back from current support2025 Historical Comparison & AI Powered Buy and Sell Recommendations - Newser
equillium inc.’s volatility index tracking explainedGold Moves & Short-Term Trading Alerts - Newser
News impact scoring models applied to Equillium Inc.Quarterly Portfolio Report & Smart Money Movement Alerts - Newser
Can technical indicators confirm Equillium Inc.’s reversal2025 Market Sentiment & Free Reliable Trade Execution Plans - Newser
Short interest data insights for Equillium Inc.2025 Stock Rankings & Expert Curated Trade Ideas - Newser
What data driven models say about Equillium Inc.’s future2025 Momentum Check & Daily Stock Momentum Reports - Newser
Technical analysis overview for Equillium Inc. stockMarket Rally & Consistent Growth Equity Picks - Newser
Using flow based indicators on Equillium Inc.2025 Risk Factors & Smart Money Movement Alerts - Newser
Sentiment analysis tools applied to Equillium Inc.Trade Analysis Summary & Real-Time Market Sentiment Alerts - Newser
Technical signs of recovery in Equillium Inc.Weekly Stock Summary & Proven Capital Preservation Methods - Newser
Is Equillium Inc. meeting your algorithmic filter criteria2025 Institutional Moves & Weekly High Return Stock Forecasts - Newser
Equillium Inc. stock trend forecastJuly 2025 Technicals & Smart Allocation Stock Tips - Newser
Exit strategy if you’re trapped in Equillium Inc.July 2025 Recap & Capital Efficient Trade Techniques - Newser
Should you wait for a breakout in Equillium Inc.2025 Price Targets & AI Optimized Trading Strategy Guides - Newser
What candlestick patterns are forming on Equillium Inc.July 2025 Outlook & Daily Momentum Trading Reports - Newser
Can volume confirm reversal in Equillium Inc.2025 Sector Review & Risk Adjusted Buy and Sell Alerts - Newser
Analyzing Equillium Inc. with multi timeframe chartsOptions Play & Weekly Breakout Watchlists - Newser
What technical models suggest about Equillium Inc.’s comebackWeekly Stock Recap & Target Return Focused Picks - Newser
Multi asset correlation models including Equillium Inc.July 2025 Volume & Community Consensus Stock Picks - Newser
Can trapped investors hope for a rebound in Equillium Inc.Trade Entry Summary & Target Return Focused Stock Picks - Newser
What does recent volatility data suggest for Equillium Inc.Market Performance Report & High Accuracy Trade Alerts - Newser
Momentum divergence signals in Equillium Inc. chart2025 Short Interest & Real-Time Chart Pattern Alerts - Newser
Can machine learning forecast Equillium Inc. recovery2025 Big Picture & Safe Entry Zone Identification - Newser
Options Data Show Bullish Bias in Equillium Inc.2025 Analyst Calls & Momentum Based Trading Signals - Newser
Equillium files for offering of up to 52.63 million shares of common stock by selling stockholdersSEC filing - MarketScreener
Does Equillium Inc. stock have upside surprise potential2025 Stock Rankings & Weekly High Potential Stock Alerts - Lancaster City Council
Equillium Inc.’s volatility index tracking explainedWeekly Profit Report & Fast Moving Market Watchlists - Newser
Chart based exit strategy for Equillium Inc.Market Performance Summary & Stepwise Entry/Exit Trade Alerts - Newser
Equillium Inc Stock (EQ) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):